Gefitinib Alone vs Gefitinib Plus Chemotherapy for NSCLC With Mutated EGFR
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non-Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 Study
J. Clin. Oncol 2019 Nov 04;[EPub Ahead of Print], Y Hosomi, S Morita, S Sugawara, T Kato, T Fukuhara, A Gemma, K Takahashi, Y Fujita, T Harada, K Minato, K Takamura, K Hagiwara, K Kobayashi, T Nukiwa, A InoueFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.